Biotech Firm Coming To Pearland

Lonza Group, a massive Swiss pharmaceutical company, plans to build a 100k SF biotech facility in Pearland that will replace Lonza’s existing Houston operations. The new facility will be on an 11-acre plot in Pearland’s Lower Kirby District.

The Pearland Economic Development Council and Lonza have been in discussions since 2014, according to the Houston Business Journal. Fort Worth-based Rogue Architects is the architect of record.

The new facility will have 100k SF of office space, labs and other areas that will facilitate the production of its viral gene and virally modified therapeutics. [HBJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Houston Newsletters
Related Stories

Logistics Company Buys Land For 1.2M SF Phoenix Industrial Park

DHS Buys 3 More Detention Facilities From The Geo Group For $950M

RN3 Enters Dutch Logistics Market With DHL Sale-Leaseback Deal

Amazon, LA Olympics Organizer Take Over 39-Acre Site Formerly Home To Forever 21

Delin Secures €227M Loan To Refinance Dutch Logistics Fund

Structural Design Decisions Can Box Owners In. The Right Partner Can Help Them Make More Informed Decisions

Fort Worth Offers Incentives To Land Nearly $200M Harting Connectivity Plant

Morgan Stanley Fund Buys 189K SF Milpitas Industrial Building

Cushman & Wakefield Wins Assignment To Sell Would-Be ICE Detention Facilities

Disgraced Houston Housing Official Sentenced For Misusing Public Funds

INSIDE THE SPACE: 8821 Preston Ct., Jessup, Maryland

Newsom Signs Bills Aimed At Cold Storage Post-Boyle Heights Fire